Enyedy Mark J
- SEC CIK
- 0001586965
No open-market purchases or sales filed in the past year.
Current role at each company
- BMRN Biomarin Pharmaceutical IncDirectoras of Jun 4, 2026
- CRL Charles River Laboratories International, Inc.Directoras of May 11, 2026
- IMGN ImmunoGen, Inc.CHIEF EXECUTIVE OFFICERas of Feb 12, 2024
- LogicBio Therapeutics, Inc.Directoras of Nov 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Enyedy Mark J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMGN ImmunoGen, Inc.
CHIEF EXECUTIVE OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 (view filing) | Aug 2-4 | 2 days | Enyedy Mark JCHIEF EXECUTIVE OFFICER | SSale | −3.01M | $17.01 | −$51.1M | −84.5%553.3K after | 4 lots |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Enyedy Mark JCHIEF EXECUTIVE OFFICER | SSale | −20.1K | $29.28 | −$588.7K | −3.3%584.4K after | 10b5-1 |